BrownleeWJAltmannDRAlvesDaMotaPet al. Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler2017; 23: 665–674.
2.
ArrambideGRoviraASastre-GarrigaJet al. Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler2018; 24: 301–312.
3.
SombekkeMHWattjesMPBalkLJet al. Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis. Neurology2013; 80: 69–75.
4.
ThompsonAJBanwellBBarkhofFet al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. Epub ahead of print 21December2017. DOI: http://dx.doi.org/10.1016/S1474-4422(17)30470-2.
5.
BrownleeWJHardyTAFazekasFet al. Diagnosis of multiple sclerosis: Progress and challenges. Lancet2017; 389: 1336–1346.
6.
DekkerISombekkeMWitteBet al. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis. Mult Scler2018; 24: 481–490.
7.
TintoreMRoviraARioJet al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain2015; 138: 1863–1874.
8.
O’RiordanJILosseffNAPhatourosCet al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatry1998; 64: 353–357.
9.
HutchinsonM. Spinal cord MRI should always be performed in clinically isolated syndrome patients: Commentary. Mult Scler2014; 20: 1690–1691.
10.
RoviraAWattjesMPTintoreMet al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol2015; 11: 471–482.
11.
TraboulseeASimonJHStoneLet al. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol2016; 37: 394–340.